SHZ · 002001.SZ
Zhejiang NHU Company Ltd.
CN¥25.60+CN¥0.16 (+0.63%)
Zhejiang NHU Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.3% below the high.
Loading market information…
SHH · 600299.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Bluestar Adisseo Company’s quoted price sits in the lower half of its reported 52-week range, 55.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bluestar Adisseo Company’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 2.72% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Bluestar Adisseo Company’s next earnings report is currently expected on Oct 31, 2026, with estimated earnings per share of CN¥0.39. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bluestar Adisseo Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bluestar Adisseo Company operates as a global leader in the development, production, and distribution of specialized feed additives for animal nutrition. The company's diverse product portfolio includes Rhodimet, a range of methionine-based solutions for monogastric animals, offered in both solid (Rhodimet NP99) and liquid (Rhodimet AT88) forms. Additionally, it provides advanced nutritional formulas, such as Smartamine and MetaSmart, which are engineered to ensure optimal amino acid balance in the diets of lactating dairy cows and other ruminants. Its Microvit range offers a comprehensive selection of vitamins essential for the feed industry. Adisseo also produces a diverse array of enzyme preparations under the Rovabio brand, formulated to enhance the digestibility of plant-based raw materials for various animal species, including poultry and swine. Another significant offering is Selisseo 2% Se, an organic selenium source based on seleno-hydroxy-methionine, designed for integration into animal feed. The firm supplies AdiSodium, a chloride-free sodium alternative that supports dietary electrolyte balance in monogastric feeds and delivers an assimilable form of sulfur to ruminant diets. Furthermore, Alterion is provided to improve animal gut health and overall performance by fostering a balanced intestinal micro-ecosystem. Complementing its product portfolio, the company provides several specialized services. PNE utilizes Near-Infrared (NIR) technology to accurately predict the nutritional quality of feed raw materials. DiM offers dedicated assistance and application support for its Rhodimet AT88 product. Lastly, E-lab is an online portal facilitating analytical requests and simplifying sample identification for customers prior to shipment to Adisseo's laboratories. Founded in 1939 and headquartered in Beijing, China, Bluestar Adisseo Company functions as a subsidiary of China National Bluestar (Group) Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:56 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥4.30B+4.29% vs estimate |
| Q4 2024 | Feb 27, 2025 | CN¥0.08-27.27% vs estimate | CN¥4.16B+0.33% vs estimate |
|---|
| Q3 2024 | Oct 29, 2024 | CN¥0.15+7.14% vs estimate | CN¥4.11B0.0% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥25.60+CN¥0.16 (+0.63%)
Zhejiang NHU Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.3% below the high.
CN¥7.33+CN¥0.08 (+1.1%)
MeiHua Holdings Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 44.64% below the high.
CN¥10.63+CN¥0.02 (+0.19%)
Zhejiang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.79% below the high.
CN¥16.27+CN¥0.06 (+0.37%)
Tianjin Ringpu Bio-Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.4% below the high.
CN¥4.07-CN¥0.02 (-0.49%)
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong’s quoted price sits in the lower half of its reported 52-week range, 50.73% below the high.
CN¥4.55-CN¥0.09 (-1.94%)
Jinhe Biotechnology Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CN¥11.48-CN¥0.26 (-2.21%)
Qingdao Vland Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.64% below the high.
CN¥9.17-CN¥1.01 (-9.92%)
Nantong Acetic Acid Chemical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.34% below the high.
